These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 33162522)

  • 21. Application of interim PET-CT in first-line treatment decision-making for lymphoma.
    Huang L; Zhao Y; He J
    J Zhejiang Univ Sci B; 2023 Oct; 24(10):905-921. PubMed ID: 37752092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frontline Therapy for Classical Hodgkin Lymphoma by Stage and Prognostic Factors.
    Allen PB; Gordon LI
    Clin Med Insights Oncol; 2017; 11():1179554917731072. PubMed ID: 28989291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hodgkin disease-an ever-evolving therapy.
    Dann EJ
    Rambam Maimonides Med J; 2014 Oct; 5(4):e0029. PubMed ID: 25386345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improving outcomes after autologous transplantation in relapsed/refractory Hodgkin lymphoma: a European expert perspective.
    Sureda A; André M; Borchmann P; da Silva MG; Gisselbrecht C; Vassilakopoulos TP; Zinzani PL; Walewski J
    BMC Cancer; 2020 Nov; 20(1):1088. PubMed ID: 33172440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Case series of BRAF-mutated advanced melanoma treated with encorafenib plus binimetinib combination therapy.
    Fujimura T; Yoshino K; Kato H; Fujisawa Y; Nakamura Y; Yamamoto Y; Kunimoto K; Ito T; Matsushita S; Maekawa T; Ohuchi K; Amagai R; Muto Y; Furudate S; Kambayashi Y; Hashimoto A; Aiba S
    J Dermatol; 2021 Mar; 48(3):397-400. PubMed ID: 33179310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apatinib combined with paclitaxel-based chemotherapy in patients with taxane-resistant advanced gastric cancer: a single-arm exploratory study.
    Zhao S; Fan N; Li H; Liu J; Huang F; Chen Y; Zhou M; Yu J; Lin R
    Ann Transl Med; 2020 Oct; 8(19):1233. PubMed ID: 33178765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immuno-priming durvalumab with bevacizumab in HER2-negative advanced breast cancer: a pilot clinical trial.
    Quintela-Fandino M; Holgado E; Manso L; Morales S; Bermejo B; Colomer R; Apala JV; Blanco R; Muñoz M; Caleiras E; Iranzo V; Martinez M; Dominguez O; Hornedo J; Gonzalez-Cortijo L; Cortes J; Gasol Cudos A; Malon D; Lopez-Alonso A; Moreno-Ortíz MC; Mouron S; Mañes S
    Breast Cancer Res; 2020 Nov; 22(1):124. PubMed ID: 33176887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Present and future perspective of the treatment of peripheral T-cell lymphoma].
    Nagai H
    Rinsho Ketsueki; 2020; 61(9):1259-1265. PubMed ID: 33162524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment strategy for newly diagnosed classical Hodgkin lymphoma: current achievements using interim PET-guided therapy].
    Kusumoto S
    Rinsho Ketsueki; 2020; 61(9):1244-1251. PubMed ID: 33162522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma.
    Johnson P; Federico M; Kirkwood A; Fosså A; Berkahn L; Carella A; d'Amore F; Enblad G; Franceschetto A; Fulham M; Luminari S; O'Doherty M; Patrick P; Roberts T; Sidra G; Stevens L; Smith P; Trotman J; Viney Z; Radford J; Barrington S
    N Engl J Med; 2016 Jun; 374(25):2419-29. PubMed ID: 27332902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Initial treatment strategy for classical Hodgkin lymphoma in adults].
    Kusumoto S
    Rinsho Ketsueki; 2021; 62(8):1102-1111. PubMed ID: 34497197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Response-adapted frontline therapy for Hodgkin lymphoma: are we there yet?
    Johnson PW
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):316-322. PubMed ID: 27913497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of first-line treatment options for patients with advanced-stage Hodgkin lymphoma: a modelling study.
    Vijenthira A; Chan K; Cheung MC; Prica A
    Lancet Haematol; 2020 Feb; 7(2):e146-e156. PubMed ID: 31948928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial.
    Gallamini A; Tarella C; Viviani S; Rossi A; Patti C; Mulé A; Picardi M; Romano A; Cantonetti M; La Nasa G; Trentin L; Bolis S; Rapezzi D; Battistini R; Gottardi D; Gavarotti P; Corradini P; Cimminiello M; Schiavotto C; Parvis G; Zanotti R; Gini G; Ferreri AJM; Viero P; Miglino M; Billio A; Avigdor A; Biggi A; Fallanca F; Ficola U; Gregianin M; Chiaravalloti A; Prosperini G; Bergesio F; Chauvie S; Pavoni C; Gianni AM; Rambaldi A
    J Clin Oncol; 2018 Feb; 36(5):454-462. PubMed ID: 29360414
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.